CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:35PM GMT
Release Date Price: R$51.97 (-0.67%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

So good morning, everyone. And for those of you who are new to the room, welcome to Morgan Stanley's Global Healthcare Conference. We're very happy to be here in person after a couple of years.

I'm Ricky Goldwasser, Morgan Stanley's Healthcare Services Analyst. I'm part of the services team. And joining me this morning are Karen Lynch, President and CEO of CVS; and Shawn Guertin, Executive VP and CFO. So good morning, Karen, Shawn. So great to have you here with us.

Karen Sue Lynch
CVS Health Corporation - President, CEO & Director

Good morning, Ricky. Great to be here.

Rivka Regina Goldwasser;Karen Sue Lynch
Morgan Stanley, Research Division - MD;CVS Health Corporation - President, CEO &

And before we start, one disclosure. For any holding regulatory disclosures, please go to the Morgan Stanley website into the research website. And with that, Karen, pass it to you for some introductory remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot